Company / Profit Margin
Haemonetics Profit Margin History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
9.0%
FY2026
5-year range
9.0% / 12.3%
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#43 of 156
Health Care
What the data says
At 9.0%, Haemonetics's profit margin ranks #43 of 156 in the Health Care sector. Profit Margin has fluctuated over the past 6 years, ranging from 4.4% in FY2021 to 20.2% in FY2017.
Based on SEC 10-K filings.
9.0% in FY2026 with a 5-year CAGR of +4.6%.
Remained stable around 9.0% over the past 3 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +0.0pp
- 5-Year Change
- +4.6pp
- 10-Year Change
- -
Sector benchmark
#43 of 156 in Health CareTop 28% of 156This company 9.0% Sector average -252.5%
▼
+103.6% above sector average
Key checks
Key Insights
- Currently 261.5pp above the Health Care sector average.
- Peak profit margin was recorded in FY2017.
- Lowest profit margin in the period was in FY2021.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | 9.0% | - |
| FY2025 | - | - |
| FY2024 | 12.3% | +37.2% |
| FY2023 | 9.0% | -9.0% |
| FY2022 | 9.9% | +125.9% |
| FY2021 | 4.4% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | 20.2% | +783.1% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026